4.6 Editorial Material

Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors

Journal

JAMA ONCOLOGY
Volume 4, Issue 12, Pages 1661-1662

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamaoncol.2018.4316

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available